{
    "id": "dbpedia_6494_2",
    "rank": 14,
    "data": {
        "url": "https://rettsyndromenews.com/author/yedida/",
        "read_more_link": "",
        "language": "en",
        "title": "Yedida Y Bogachkov PhD, Author at Rett Syndrome News",
        "top_image": "https://secure.gravatar.com/avatar/ad8d4f029490faf917df711120b025c1.jpg?d=mp&s=1200",
        "meta_img": "https://secure.gravatar.com/avatar/ad8d4f029490faf917df711120b025c1.jpg?d=mp&s=1200",
        "images": [
            "https://insight.bionewsservices.com/matomo.php?idsite=9&rec=1",
            "https://rettsyndromenews.com/wp-content/uploads/2023/06/RETTnews.png",
            "https://rettsyndromenews.com/wp-content/uploads/2021/05/color-fb.png",
            "https://rettsyndromenews.com/wp-content/uploads/2021/05/color-fb.png",
            "https://rettsyndromenews.com/wp-content/uploads/2021/10/Head-Shot-8.20.21-96x96.jpg",
            "https://bionews.com/global-code/images/linkedin.png",
            "https://rettsyndromenews.com/wp-content/uploads/2024/06/BionewsLogo_Black.svg",
            "https://rettsyndromenews.com/wp-content/uploads/2021/05/color-fb.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [
            "Yedida Y Bogachkov PhD"
        ],
        "publish_date": null,
        "summary": "",
        "meta_description": "Yedida Y. Bogachkov is a science writer for BioNews. She holds a PhD in cellular and molecular pharmacology from the University of Illinois at Chicago. Prior to joining BioNews, she was conducting scientific research analyzing cancer genomics. She’s a Chicago native and hasn’t moved out of her...",
        "meta_lang": "en",
        "meta_favicon": "https://rettsyndromenews.com/wp-content/uploads/2024/06/Bionews_Favicon-1.svg",
        "meta_site_name": "Rett Syndrome News",
        "canonical_link": "https://rettsyndromenews.com/author/yedida/",
        "text": "Acadia, Stoke Team Up in $60M Deal to Develop RNA-based Therapies\n\nAcadia Pharmaceuticals and Stoke Therapeutics are teaming up to develop and commercialize new RNA-based therapies — using Stoke’s proprietary research platform, TANGO — for the potential treatment of Rett syndrome. As part of the collaboration, Stoke will receive a $60 million upfront payment from Acadia. “Stoke’s…\n\nChildren’s Hospital Los Angeles Expands Space for Rett Care\n\nThe Rett Syndrome Clinic at Children’s Hospital Los Angeles has been relaunched in an expanded space and expects to enhance individualized care for children with the disorder. The new Neurological Institute Outpatient Center opened this year at the hospital’s Sunset Boulevard campus. It aims to provide comprehensive care for children…\n\nUnusually High Number of Mitochondrial DNA Seen in Patients\n\nThe copy number of mitochondrial DNA (mtDNA) is increased significantly in patients with Rett syndrome, possibly indicating mitochondrial dysfunction, a study reported. Researchers suggest that this increase in the copy number of mtDNA is an attempt to compensate for decreased energy availability. Mitochondria are the producers of energy within…\n\nHive Networks, IRSF Team Up to Create Digital Health Platform\n\nHive Networks, a digital health company, is teaming up with the International Rett Syndrome Foundation (IRSF) to provide a cloud platform to support patients, caregivers, and researchers in the Rett community. The multi-year partnership — being announced in the midst of Rett Syndrome Awareness Month — aims to…"
    }
}